Obesity is a cause of significant mortality and morbidity in the UK with currently 26% of adults in the UK clinically obese 1 . Bariatric surgery has been shown to be an effec@ve treatment for obesity, giving significant weight loss as well puDng type 2 diabetes, hypertension, hyperlipidaemia and obstruc@ve sleep apnoea (OSA) into remission. 2,3,4 However there is a disparity in the number of men accessing bariatric services, with only 19% of bariatric pa@ents being male. 5 To aid our understanding of this disparity, it is important to ascertain whether metabolic outcomes aOer bariatric surgery differ between genders, as this may be a poten@al barrier for accessing treatment.
This study examined changes in several metabolic outcomes aOer bariatric surgery in adult males and females: Body Mass Index (BMI), Blood Pressure, Total Cholesterol: HDL ra@o and HbA1c (in pa@ents with a diagnosis of Type 2 Diabetes Mellitus). Further to these factors, this study also inves@gated changes in several clinical variables: the use of CPAP therapy for OSA, and the prescrip@on of diabe@c medica@ons --with par@cular regard given to the use of Insulin before and aOer surgery. This will enable us to highlight any gender differences in the outcomes of bariatric surgery, which in turn will allow for a greater understanding of the disparity in access to bariatric surgical services in men and women.
Materials and methods
The study highlighted adult pa@ents who underwent bariatric surgery at Salford Royal Hospital, Manchester in a three--year period. A number of variables were recorded: age at @me of surgery, type of surgery, diabetes diagnosis and corresponding medica@ons par@cularly insulin, HbA1c, height, weight, systolic and diastolic blood pressure, total cholesterol: high--density lipoprotein (HDL) ra@o, and OSA treated with CPAP. Data was recorded for 12 months, 6 months and 3 months prior to surgery as well as at the @me of surgery to give a mean preopera@ve result. Outcomes following surgery were recorded at 6 weeks, 4 months, 12 months, 24 months and 36 months aOer surgery. As there was a much greater number of women iden@fied, data for all males was captured and matched to women of equal age (±5 years), BMI (±2kg/m 2 ), Type 2 Diabetes diagnosis, and consequent insulin therapy, and CPAP therapy for OSA. Data was sta@s@cally analysed for significant difference between men and women by unpaired T--test. Fisher's tests were used to compare 2x2 tables of data for CPAP therapy and insulin use.
! Weight loss and metabolic outcomes aOer bariatric surgery are of similar magnitude in men compared to women. ! The use of bariatric surgery in eligible men should be encouraged. ! Further work is required to understand the current gender disparity in uptake of bariatric surgery. 34 matched men and women had a diagnosis of type 2 diabetes prior to surgery. Of these, seven (22.5%) were prescribed insulin. Following surgery, no men and one woman remained on insulin (P=0.5256). In terms of glycaemic control, there is no sta@s@cal difference between men and women in HbA1c (P=0.1040 at 24 months).
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